

If so, you may have a possible legal case against the manufacturer of the potentially dangerous drug or medical product. Simply fill out the short form below and an experienced legal expert will contact you as soon as possible!
Added September 5th, 2006

An injectable version of a drug used to treat schizophrenia could cause far fewer side effects according to researchers that have carried out clinical trials. It is claimed that the injectable version of Risperdal is a slow release formula that can really reduce the risk of side effects as well as the number of effects from taking the medication.
Risperdal has been used in tablet form to treat schizophrenia, but there were reports of a variety of side effects, some of which included weight gain, lack of energy, constipation, and sexual dysfunction. Studies have been carried out in the past showing that around three quarters of patients with the illness come off their medication at some point because of the side effects.
Dr. Pierre Chue, a psychiatrist in Edmonton stated: "As a consequence of that, people will often end up being in hospital; they may make an attempt on their lives, may become aggressive."
However, it is feared that although the new slow release formula could be far more beneficial for patients, many sufferers in Canada may not be able to get it due to cost implications. Chue added: "We don't have full reimbursement in every province across Canada, which I think is the reason why it's not widely used."

Fewer Side Effects... | Printable Version (Opens In New Window)